Evaluation the TECNIS IOL in Both Eyes VS the ReZoom IOL in One and TECNIS IOL in the Opposite
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01253239 |
Recruitment Status :
Completed
First Posted : December 3, 2010
Last Update Posted : July 20, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cataract |
Stable post operative cataract and clear lens extraction patients who have been implanted with either the TECNIS Multifocal IOL in both eyes or TECNIS Multifocal IOL in one eye and theReZoom Multifocal IOL in the opposite eye.
Study Design-A retrospective chart review to collect visual outcomes to determine lens performance. Patient satisfaction questionnaire will be administered to determine spectacle independence.
Study Type : | Observational |
Actual Enrollment : | 175 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | A Retrospective Evaluation Comparing Post Operative Visual Outcomes in Patients Implanted With the TECNIS IOL in Both Eyes Versus the ReZoom IOL in One Eye and TECNIS IOL in the Opposite Eye |
Study Start Date : | November 2010 |
Actual Primary Completion Date : | July 2015 |
Actual Study Completion Date : | July 2015 |
Group/Cohort |
---|
TECNIS/ReZoom
Patients who received a TECNIS multifocal IOL in one eye and a ReZoom multifocal IOL in the opposite eye.
|
TECNIS/TECNIS
Patients who received TECNIS multifocal IOLs in both eyes
|
- Uncorrected visual acuity at distance and near [ Time Frame: Six months ]
- Patients Satisfaction [ Time Frame: Six months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 42 Years to 86 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients who have undergone surgery and received either the TECNIS Multifocal Intraocular lens in one eye and the ReZoom Multifocal Intraocular lens in the other will be evaluated. Males and Females with ages ranging from 42 years to 86 years old.
Exclusion Criteria:
- Patients who have subsequently developed any visual limiting problems (e.g. corneal, retinal, infection) which could potentially limit their post operative visual potential.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01253239
United States, Pennsylvania | |
Bucci Laser Vision Institute | |
Wilkes-Barre, Pennsylvania, United States, 18702 |
Principal Investigator: | Frank A Bucci, Jr., MD | Bucci Laser Vision Institute |
Responsible Party: | Frank A. Bucci, Jr., M.D., Principal Investigator, Bucci Laser Vision Institute |
ClinicalTrials.gov Identifier: | NCT01253239 |
Other Study ID Numbers: |
TECNIS-ReZoom-2010 |
First Posted: | December 3, 2010 Key Record Dates |
Last Update Posted: | July 20, 2016 |
Last Verified: | July 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Visual outcomes Patient satisfaction |
Cataract Lens Diseases Eye Diseases |